Literature DB >> 5302595

Control of pain in the rheumatic disorders.

F D Hart.   

Abstract

Pain may be attacked in the rheumatic diseases (1) centrally, with drugs ranging in efficiency from those which are potentially addictive and under the Dangerous Drugs Act (e.g., pethidine) and are therefore rarely used, down to simple analgesics such as paracetamol; (2) peripherally, by local action, whether it be by applications of heat or cold, by injections of local anaesthetics or anti-inflammatory agents, or by surgery; (3) peripherally, by anti-inflammatory non-analgesic agents taken systemically, such as the corticosteroids; and (4) peripherally, by anti-inflammatory-analgesic-antipyretic agents taken systemically, such as aspirin.The exact sites of action of the pyrazoles, indomethacin, the anthranilic compounds, and other anti-inflammatory-analgesic-antipyretic drugs are as yet uncertain, but along with these methods of attacking the pain-producing areas help must also be given to the distressed mind behind the joints. Faith in the future, cheerfulness, freedom from depression, and the development of a philosophy to deal with the uncertainties of the disease are essential. It has been said that you don't have to be a doctor to treat uncomplicated lobar pneumonia: anybody with a bottle of penicillin in his hands holds the cure. It is the incurable diseases that are really worth treating, and that make demands on the physician. To quote Tuker: "My last word is this. Whoever has the care of a sorely stricken arthritic must encourage him to fulfil himself intellectually and spiritually, and to achieve-no matter what, but to achieve, so that he may nightly lay himself down on his bed of pain looking forward happily to the morrow's task, mind centred upon it, no matter what it is; sticking in stamps, research into anything you like, dabbling with pastel or water colours, writing chatty letters to friends. Anything at all, but let it be for him the most pressing thing of the day, and let him believe that you think it is. Help him and let him live, live fully."This is perhaps the best analgesic of all.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5302595      PMCID: PMC1986525          DOI: 10.1136/bmj.3.5619.635

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  208.--INDOMETHACIN IN THE TREATMENT OF ACUTE GOUT.

Authors:  P L BOARDMAN; F HARTDUDLEY
Journal:  Practitioner       Date:  1965-04

2.  INDOMETHACIN: STUDIES OF ABSORPTION AND OF THE USE OF INDOMETHACIN SUPPOSITORIES.

Authors:  L P HOLT; C F HAWKINS
Journal:  Br Med J       Date:  1965-05-22

3.  THE BURSAE OF THE BODY.

Authors:  E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1965-05       Impact factor: 19.103

4.  Thorax in ankylosing spondylitis.

Authors:  F D HART; P A EMERSON; I GREGG
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

5.  A critical survey of the value of radiotheapy in the treatment of ankylosing spondylitis.

Authors:  F D HART
Journal:  Clin Radiol       Date:  1961-04       Impact factor: 2.350

6.  Peripheral entrapment neuropathies of the upper extremity.

Authors:  W A THOMPSON; H P KOPELL
Journal:  N Engl J Med       Date:  1959-06-18       Impact factor: 91.245

7.  Pain-sensitivity tests; the pressure algometer.

Authors:  K D KEELE
Journal:  Lancet       Date:  1954-03-27       Impact factor: 79.321

Review 8.  The stiff aching back. The differential diagnosis of ankylosing spondylitis.

Authors:  F D Hart
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

9.  Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors:  P L Boardman; F D Hart
Journal:  Br Med J       Date:  1967-11-04

10.  Pain complaint threshold in relation to pain of cardiac infarction.

Authors:  K D Keele
Journal:  Br Med J       Date:  1968-03-16
  10 in total
  1 in total

1.  Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos.

Authors:  G Nuki; W W Downie; W C Dick; K Whaley; J B Spooner; M A Darby-Dowman; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.